Press Release: Corvidia : Corvidia Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 8, 2020 /PRNewswire/ -- Corvidia Therapeutics Inc., a clinical stage company focused on the research, development and commercialization of transformative therapies in cardio-renal disease, today announced the company will present at the 38th Annual J.P. Morgan...